Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 16, 2021Frontiers in NeurologyOpen Access

Gender Differences in 3-Month Outcomes of Erenumab Treatment—Study on Efficacy and Safety of Treatment With Erenumab in Men

View Full Paper
Ask AI
Bookmark
Share

Authors

RORaffaele OrnelloUniversity of L'AquilaCBCarlo BaraldiUniversity of Modena and Reggio EmiliaSGSimona GuérzoniPoliclinico Universitario di Catania

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ornello et al. (2021) studied this question.

synapsesocial.com/papers/6a99af49574e6d0e8595b324https://doi.org/10.3389/fneur.2021.774341
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Female Sex Hormones and Rat Dural Vasodilatation to CGRP, Periarterial Electrical Stimulation and Capsaicin2006 · 57 citations
  2. 2A prospective real-world analysis of erenumab in refractory chronic migraine2020 · 199 citations
  3. 3Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study2020 · 92 citations